HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
EVC2
EvC ciliary complex subunit 2
Chromosome 4 Β· 4p16.2
NCBI Gene: 132884Ensembl: ENSG00000173040.14HGNC: HGNC:19747UniProt: Q86UK5
39PubMed Papers
22Diseases
0Drugs
337Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
nucleusplasma membrane protein complexciliary membranesmoothened signaling pathwayEllis-van Creveld syndromeacrofacial dysostosis, Weyers typeEllis Van Creveld syndromegenetic disorder
✦AI Summary

EVC2 is a component of the EvC ciliary complex that positively regulates Hedgehog (Hh) signaling, a pathway essential for skeletal and craniofacial development 1. The protein localizes to ciliary and plasma membrane compartments where it modulates smoothened signaling 2. Loss-of-function mutations in EVC2 impair Hh signaling output, disrupting normal morphogenesis and differentiation of developing tissues 12. EVC2 mutations cause Ellis-van Creveld (EVC) syndrome, an autosomal recessive skeletal ciliopathy characterized by short stature, short limbs, polydactyly, and congenital cardiac defectsβ€”particularly atrial septal abnormalities occurring in ~60% of cases 34. Heterozygous EVC2 mutations in the terminal exon cause the milder phenotype of Weyers acrofacial dysostosis 5. EVC2 shows predominant expression in craniofacial tissues compared to EVC 2, and evolutionary analysis suggests human-specific down-regulation of EVC2 contributed to unique human craniofacial morphology 1. Biallelic mutations in EVC2 represent approximately 26-36% of molecularly confirmed EVC syndrome cases, with missense variants generally associated with milder phenotypes than frameshift or truncating mutations 45. Clinical management focuses on addressing respiratory compromise from thoracic narrowing and cardiac complications.

Sources cited
1
EVC2 is a key hedgehog gene with human-specific down-regulation; reducing EVC2 substantially decreases hedgehog signaling output; EVC2 deficiency produces craniofacial phenotypes paralleling human-chimpanzee differences
PMID: 33731941
2
EVC2 is a component of the EvC ciliary complex regulating Hedgehog signaling; predominant expression of EVC2 in craniofacial tissues; biallelic mutations affect ciliary function and morphogenesis
PMID: 35393766
3
Ellis-van Creveld syndrome characterized by short ribs, polydactyly, growth retardation, heart defects; caused by EVC or EVC2 mutations; cardiac defects occur in ~60% of cases; autosomal recessive inheritance
PMID: 17547743
4
EVC2 mutations represent 26% of molecularly confirmed EVC syndrome cases; biallelic cases with missense variants show milder phenotypes than truncating mutations; heterozygous forms show less expressivity
PMID: 39669252
5
EVC2 mutations cause both Ellis-van Creveld syndrome and Weyers acrofacial dysostosis; last exon of EVC2 is a hotspot for Weyers dysostosis mutations; allelic disorders with different phenotypic severity
PMID: 23220543
6
Skeletal ciliopathies including EVC syndrome involve defects in ciliary biosynthesis and function; ciliary complex mutations cause skeletal abnormalities including short ribs and polydactyly
PMID: 29068549
Disease Associationsβ“˜22
Ellis-van Creveld syndromeOpen Targets
0.81Strong
acrofacial dysostosis, Weyers typeOpen Targets
0.80Strong
Ellis Van Creveld syndromeOpen Targets
0.76Strong
genetic disorderOpen Targets
0.50Moderate
Jeune syndromeOpen Targets
0.49Moderate
short-rib thoracic dysplasia 6 with or without polydactylyOpen Targets
0.42Moderate
Beemer-Langer syndromeOpen Targets
0.40Weak
cervical carcinomaOpen Targets
0.36Weak
DNA methylationOpen Targets
0.31Weak
multiple sclerosisOpen Targets
0.27Weak
alopecia areataOpen Targets
0.26Weak
Meckel syndromeOpen Targets
0.26Weak
Paralytic ileusOpen Targets
0.25Weak
tooth agenesis, selective, 2Open Targets
0.12Weak
COVID-19Open Targets
0.10Suggestive
severe acute respiratory syndromeOpen Targets
0.10Suggestive
osteochondrodysplasiaOpen Targets
0.09Suggestive
arthritisOpen Targets
0.08Suggestive
Acromesomelic dysplasia, Grebe typeOpen Targets
0.07Suggestive
lethal faciocardiomelic dysplasiaOpen Targets
0.06Suggestive
Acrofacial dysostosis, Weyers typeUniProt
Ellis-van Creveld syndromeUniProt
Pathogenic Variants337
NM_147127.5(EVC2):c.3659+2T>CPathogenic
Ellis-van Creveld syndrome|not provided|Ellis-van Creveld syndrome;Curry-Hall syndrome|EVC2-related disorder
β˜…β˜…β˜†β˜†2026
NM_147127.5(EVC2):c.1195C>T (p.Arg399Ter)Pathogenic
Ellis-van Creveld syndrome|Short-rib thoracic dysplasia 6 with or without polydactyly|not provided|Ellis-van Creveld syndrome;Curry-Hall syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 399
NM_147127.5(EVC2):c.264C>A (p.Cys88Ter)Pathogenic
not provided|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 88
NM_147127.5(EVC2):c.3660del (p.Ser1220fs)Pathogenic
Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 1220
NM_147127.5(EVC2):c.133C>T (p.Gln45Ter)Pathogenic
Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 45
NM_147127.5(EVC2):c.1024A>T (p.Lys342Ter)Pathogenic
Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome|Curry-Hall syndrome|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 342
NM_147127.5(EVC2):c.1708C>T (p.Gln570Ter)Pathogenic
Short-rib thoracic dysplasia 6 with or without polydactyly|Type IV short rib polydactyly syndrome|Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|not provided|Familial cancer of breast
β˜…β˜…β˜†β˜†2025β†’ Residue 570
NM_147127.5(EVC2):c.2484G>A (p.Trp828Ter)Pathogenic
Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 828
NM_147127.5(EVC2):c.222_228+21delLikely pathogenic
Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome
β˜…β˜…β˜†β˜†2025
NM_147127.5(EVC2):c.341C>G (p.Ser114Ter)Pathogenic
Ellis-van Creveld syndrome;Curry-Hall syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 114
NM_147127.5(EVC2):c.3265C>T (p.Gln1089Ter)Pathogenic
Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome|Inborn genetic diseases|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1089
NM_147127.5(EVC2):c.534dup (p.Glu179Ter)Pathogenic
Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 179
NM_147127.5(EVC2):c.817-2A>GLikely pathogenic
Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome
β˜…β˜…β˜†β˜†2025
NM_147127.5(EVC2):c.3405_3411del (p.Gly1136fs)Pathogenic
not provided|Jeune thoracic dystrophy|Curry-Hall syndrome;Ellis-van Creveld syndrome|EVC2-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 1136
NM_147127.5(EVC2):c.3121C>T (p.Gln1041Ter)Pathogenic
Type IV short rib polydactyly syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|Ellis-van Creveld syndrome|EVC2-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 1041
NM_147127.5(EVC2):c.273dup (p.Lys92Ter)Pathogenic
Ellis-van Creveld syndrome;Curry-Hall syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 92
NM_147127.5(EVC2):c.2047-2A>GLikely pathogenic
Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome
β˜…β˜…β˜†β˜†2025
NM_147127.5(EVC2):c.2263C>T (p.Gln755Ter)Pathogenic
Ellis-van Creveld syndrome|not provided|Curry-Hall syndrome;Ellis-van Creveld syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 755
NM_147127.5(EVC2):c.229-2A>GLikely pathogenic
Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|Thyroid cancer, nonmedullary, 1
β˜…β˜…β˜†β˜†2025
NM_147127.5(EVC2):c.450+2T>CLikely pathogenic
Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome
β˜…β˜…β˜†β˜†2025
View on ClinVar β†—
Related Genes
DISP2Shared pathway100%IQCEProtein interaction100%EFCAB7Protein interaction100%GLI2Protein interaction98%SMOProtein interaction98%SUFUProtein interaction98%
Tissue Expression6 tissues
Ovary
100%
Lung
24%
Heart
20%
Brain
9%
Liver
9%
Bone Marrow
5%
Gene Interaction Network
Click a node to explore
EVC2DISP2IQCEEFCAB7GLI2SMOSUFU
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q86UK5
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.09LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.95 [0.83–1.09]
RankingsWhere EVC2 stands among ~20K protein-coding genes
  • #10,317of 20,598
    Most Researched39
  • #175of 5,498
    Most Pathogenic Variants337 Β· top 5%
  • #11,130of 17,882
    Most Constrained (LOEUF)1.09
Genes detectedEVC2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies.
PMID: 29068549
Hum Mutat Β· 2018
1.00
2
Human Genetics of Ventricular Septal Defect.
PMID: 38884729
Adv Exp Med Biol Β· 2024
0.90
3
Human-chimpanzee fused cells reveal cis-regulatory divergence underlying skeletal evolution.
PMID: 33731941
Nat Genet Β· 2021
0.80
4
Ellis-van Creveld syndrome.
PMID: 17547743
Orphanet J Rare Dis Β· 2007
0.70
5
Establishing an objective clinical spectrum, genotype-phenotype correlations, and
PMID: 39669252
Genet Med Open Β· 2023
0.60